Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-026068
Filing Date
2025-02-25
Accepted
2025-02-25 07:10:25
Documents
98
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K fulc-20241231.htm   iXBRL 10-K 2983104
2 EX-10.16 fulc-ex10_16.htm EX-10.16 32809
3 EX-19.1 fulc-ex19_1.htm EX-19.1 86240
4 EX-23.1 fulc-ex23_1.htm EX-23.1 12137
5 EX-31.1 fulc-ex31_1.htm EX-31.1 13403
6 EX-31.2 fulc-ex31_2.htm EX-31.2 13225
7 EX-32.1 fulc-ex32_1.htm EX-32.1 7573
8 EX-32.2 fulc-ex32_2.htm EX-32.2 7536
9 GRAPHIC img45798566_0.jpg GRAPHIC 153867
10 GRAPHIC img45798566_1.jpg GRAPHIC 54405
11 GRAPHIC img45798566_2.jpg GRAPHIC 62961
12 GRAPHIC img45798566_3.jpg GRAPHIC 45797
13 GRAPHIC img45798566_4.jpg GRAPHIC 47430
14 GRAPHIC img45798566_5.jpg GRAPHIC 111497
15 GRAPHIC img45798566_6.jpg GRAPHIC 237283
16 GRAPHIC img45798566_7.jpg GRAPHIC 143316
17 GRAPHIC img45798566_8.jpg GRAPHIC 108196
  Complete submission text file 0000950170-25-026068.txt   13734550

Data Files

Seq Description Document Type Size
18 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT fulc-20241231.xsd EX-101.SCH 1601119
101 EXTRACTED XBRL INSTANCE DOCUMENT fulc-20241231_htm.xml XML 1909020
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 617-651-8851
Fulcrum Therapeutics, Inc. (Filer) CIK: 0001680581 (see all company filings)

EIN.: 474839948 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38978 | Film No.: 25659378
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)